Short Interest in Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Increases By 53.0%

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) saw a significant growth in short interest in July. As of July 31st, there was short interest totaling 5,913 shares, a growth of 53.0% from the July 15th total of 3,865 shares. Approximately 4.5% of the company’s stock are short sold. Based on an average daily volume of 3,042 shares, the short-interest ratio is currently 1.9 days.

Insiders Place Their Bets

In related news, insider Helen Louise Collins sold 5,000 shares of the company’s stock in a transaction on Friday, July 17th. The stock was sold at an average price of $52.67, for a total transaction of $263,350.00. Following the transaction, the insider directly owned 25,000 shares of the company’s stock, valued at approximately $1,316,750. The trade was a 16.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Lori Anne Kunkel sold 10,000 shares of the stock in a transaction dated Monday, July 6th. The stock was sold at an average price of $50.49, for a total value of $504,900.00. Following the completion of the sale, the director directly owned 41,884 shares of the company’s stock, valued at approximately $2,114,723.16. This represents a 19.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,342,362 shares of company stock valued at $63,158,240 over the last quarter. 37.30% of the stock is owned by insiders.

Bitwise MARA Option Income Strategy ETF Price Performance

NYSEARCA:IMRA opened at $14.59 on Wednesday. Bitwise MARA Option Income Strategy ETF has a fifty-two week low of $11.99 and a fifty-two week high of $42.32. The stock’s 50-day moving average is $15.68 and its two-hundred day moving average is $15.24. The stock has a market cap of $1.90 million, a PE ratio of 291.80 and a beta of 2.74.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2?related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.